台股 » 國光生 » 個股財報 » 每月營收

國光生

(4142)
可現股當沖
  • 股價
    21.25
  • 漲跌
    ▼0.40
  • 漲幅
    -1.85%
  • 成交量
    689
  • 產業
    上市 生技醫療類股 ▼1.83%
  • 本地時間:14:30

    633人加入追蹤

    立即追蹤

國光生 (4142) 財務報表-每月營收
月營收報表

因應IFRSs國際會計準則,本報表在2013年以前為「個別營收」,2013年以後為「合併營收」。

國光生 (4142) 月營收分析比較圖

國光生 (4142) 月營收報表

年度/月份營業收入(單位:千元)累計營業收入(單位:千元)
單月營收去年同月營收單月月增率單月年增率累計營收去年累計營收累積年增率
2024/1120,513154,394-95.7%-86.7%1,512,4261,880,689-19.6%
2024/10479,993500,69140.8%-4.1%1,491,9131,726,295-13.6%
2024/09340,997237,28183.2%43.7%1,011,9201,225,604-17.4%
2024/08186,131624,945-48.5%-70.2%670,924988,323-32.1%
2024/07361,114111,119403.3%225%484,792363,37833.4%
2024/0671,74737,7745095.3%89.9%123,678252,259-51%
2024/051,3811,997-79.3%-30.8%51,931214,485-75.8%
2024/046,67242,778-80%-84.4%50,551212,488-76.2%
2024/0333,40389,676345.8%-62.8%43,879169,710-74.1%
2024/027,49240,825151.1%-81.6%10,47680,034-86.9%
2024/012,98439,209-97.9%-92.4%2,98439,209-92.4%
2023/12142,743207,592-7.5%-31.2%2,023,4322,251,625-10.1%
2023/11154,394106,205-69.2%45.4%1,880,6892,044,033-8%
2023/10500,691270,805111%84.9%1,726,2951,937,828-10.9%
2023/09237,281700,805-62%-66.1%1,225,6041,667,022-26.5%
2023/08624,945109,142462.4%472.6%988,323966,2172.3%
2023/07111,119277,341194.2%-59.9%363,378857,075-57.6%
2023/0637,774491,4331791.5%-92.3%252,259579,734-56.5%
2023/051,99720,211-95.3%-90.1%214,48588,300142.9%
2023/0442,77815,291-52.3%179.8%212,48868,089212.1%
2023/0389,67619,795119.7%353%169,71052,798221.4%
2023/0240,82529,9014.1%36.5%80,03433,003142.5%
2023/0139,2093,102-81.1%1164%39,2093,1021164%
2022/12207,59253,44795.5%288.4%2,251,6251,641,06137.2%
2022/11106,205210,279-60.8%-49.5%2,044,0331,587,61428.7%
2022/10270,805529,052-61.3%-48.8%1,937,8281,377,33540.7%
2022/09700,805464,745542.1%50.8%1,667,022848,28396.5%
2022/08109,142235,780-60.6%-53.7%966,217383,538151.9%
2022/07277,34152,811-43.6%425.1%857,075147,757480%
2022/06491,43368,9322331.5%612.9%579,73494,946510.6%
2022/0520,21117,10632.2%18.1%88,30026,014239.4%
2022/0415,2911,977-22.8%673.4%68,0898,908664.3%
2022/0319,7954,955-33.8%299.5%52,7986,931661.8%
2022/0229,9011,155863.9%2488.8%33,0031,9751571%
2022/013,102821-94.2%277.8%3,102821277.8%
2021/1253,447127,434-74.6%-58%1,641,0611,869,160-12.2%
國光生財報/前三季稅後淨損1.94億元 每股淨損0.46元UDN聯合新聞網-28天前
國光生去年營運轉虧 今年拚重回成長軌道Anue鉅亨-2024/03/13
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
國光生 相關文章